How many studies have been conducted on Amyloid Beta Peptides?

BiohacksAI has indexed 299 PubMed studies on Amyloid Beta Peptides. 18% of studies involve human subjects.

What are the main research areas for Amyloid Beta Peptides?

The primary research domains for Amyloid Beta Peptides are 🧠 Neuroprotection, 🔬 Oncology, ⏳ Longevity & Aging. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Amyloid Beta Peptides

An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.

299+ PubMed studies analyzed · Evidence Score: 39.3

Research Domains

Amyloid Beta Peptides has been studied across 19 research domains including 🧠 Neuroprotection, 🔬 Oncology, ⏳ Longevity & Aging, 🧠 Memory, 🔥 Metabolic. The primary research focus is 🧠 Neuroprotection with 97% of studies addressing this area.

Loading evidence profile...

This evidence profile for Amyloid Beta Peptides is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.